Screener
Viridian Therapeutics, Inc. VRDN Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
FAQ
- What is Viridian Therapeutics, Inc.'s net margin?
- Viridian Therapeutics, Inc. (VRDN) reported net margin of -544.1% in Q2 2026.
- How has Viridian Therapeutics, Inc.'s net margin changed year-over-year?
- Viridian Therapeutics, Inc.'s net margin increased by 99.5% year-over-year, from -112,806.9% to -544.1%.
- What is the long-term trend for Viridian Therapeutics, Inc.'s net margin?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s net margin has grown at a -46.0% compound annual growth rate (CAGR), from -10,544.3% to -483.6%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Viridian Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude